mail2

Spectrum Library

Neuromyelitis optica spectrum disorder in Western Mexico

Publication Date March 2022

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders

Publication Date October 2021

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis

Publication Date May 2021

Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence

Publication Date August 2021

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis

Publication Date April 2021

No strong HLA association with MOG antibody disease in the UK population

Publication Date July 2021

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis

Publication Date May 2021

Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.

Publication Date February 2021

Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK

Publication Date October 2021

Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study

Publication Date September 2021

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

Publication Date September 2021

Molecular Level Characterization of Circulating Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder

Publication Date June 2021

Launch Dashboard

Dashboard

Fast Facts about NMOSD

NMOSD Symptoms Treatment Relapse Diagnosis Doctors Research News Advocate Helpline Resilience Events